Stock NGNE NEUROGENE INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Chart Neurogene Inc.

Equities

NGNE

US64135M1053

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-15 pm EDT 		5-day change 1st Jan Change
33.59 USD +6.47% Intraday chart for Neurogene Inc. +2.10% +73.32%
May. 10 Neurogene Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
May. 07 Neurogene Presents Favorable Safety Data from Phase 1/2 Trial of Ngn-401 Gene Therapy for Rett Syndrome During Asgct Annual Meeting CI
22a78.xJgtqBTUZFkt3pFGPQf-444jtXSTEUtEKheBZ0eTpCI.hcxY-SKnUQ0eiuIWckyJrvZg-iulen0iXVLQBSvCk0CO8n2dZbgSFGW08g~e3248ae36ca43679034f22594eb9c3a1
  1. Stock Market
  2. Equities
  3. NGNE Stock
  4. Charts Neurogene Inc.
  5. News Chart
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW